Brief: Hamlet Pharma AB Gets Sek 12,95 mln
03/02/2020 08:37
Feb 3 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* HAMLET PHARMA AB - GETS SEK 12,95 MILLION
* HAMLET PHARMA AB - NO ISSUE COSTS ARE PAID, SO CO IS TO GET ENTIRE SUM
Source text for Eikon: ID:nWkr9Lfd8c
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe